About hVIVO
hVIVO is a company based in London (United Kingdom) founded in 1998. The company has 133 employees as of January 31, 2022. hVIVO has completed 3 acquisitions, including Activiomics, Cryo Store and Cryostore. hVIVO offers products and services including Human Challenge Trials, Laboratory Services, and Clinical Trial Recruitment. hVIVO operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter London, United Kingdom
- Employees 133 as on 31 Jan, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hvivo Plc
-
Annual Revenue
$78.6 M (USD)11.92as on Dec 31, 2024
-
Net Profit
$13.34 M (USD)-33.9as on Dec 31, 2024
-
EBITDA
$16.19 M (USD)26.76as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
IP Group
& 1 more
-
Employee Count
133
as on Jan 31, 2022
-
Investments & Acquisitions
Activiomics
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of hVIVO
hVIVO is a publicly listed company on the LSE with ticker symbol HVO in UK, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of hVIVO
hVIVO offers a comprehensive portfolio of products and services, including Human Challenge Trials, Laboratory Services, and Clinical Trial Recruitment.
Controlled testing of vaccines for infectious diseases in volunteers.
Analysis and support for clinical trials on respiratory illnesses.
Recruitment and management of volunteers for medical research studies.
People of hVIVO
Unlock access to complete
Funding Insights of hVIVO
Investors in hVIVO
hVIVO has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include IP Group and Woodford Investment Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and advisory services are offered across multiple sectors.
|
Locked | Locked | Locked | |
|
Diversified investment portfolios are managed for clients by the firm.
|
Locked | Locked | Locked |
Investor details for hVIVO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by hVIVO
hVIVO has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Activiomics, Cryo Store and Cryostore.
Investment portfolio details for hVIVO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Phosphoproteomic solutions are offered for biomarker discovery and drug development.
|
Locked | Locked | 2009 | Locked | |
|
Tools for biostorage
|
Locked | Locked | 1999 | Locked | |
|
Secure, temperature-controlled storage is provided for biological and clinical materials.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for hVIVO
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - hVIVO
Detailed financials for hVIVO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hvivo Comparisons
Peer comparison for hVIVO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of hVIVO
hVIVO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
Detailed competitors of hVIVO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hvivo
Complete news archive for hVIVO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about hVIVO
hVIVO was founded in 1998 and raised its 1st funding round 17 years after it was founded.
hVIVO is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Jan 31, 2022, the latest employee count at hVIVO is 133.
Annual revenue of hVIVO is $78.6M as on Dec 31, 2024.
hVIVO was founded in 1998 and is headquartered in London, United Kingdom. Operations focus on the biopharma sector, where cell-based assays, field trials, and molecular services are delivered to support research and development. These offerings assist in drug discovery and validation processes, with activities centered in the UK and extending to international clients through the hvivo.com domain.
hVIVO's top competitors include Emmes, Syneos Health and ClinChoice.
hVIVO offers Human Challenge Trials, Laboratory Services, and Clinical Trial Recruitment.
Yes, hVIVO is publicly traded on LSE under the ticker symbol HVO.
hVIVO has made 3 acquisitions, including Activiomics, Cryo Store, and Cryostore.
hVIVO has 2 investors. Key investors include IP Group, and Woodford Investment Management.
The ticker symbol of hVIVO is HVO on LSE.